Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
复制标题
与阿胡斯相关的105种H因子变异体的功能特征:变异体分类的经验教训
DOI:
10.1182/blood.2021012037
复制
发表时间:
2021-12-02
期刊:
影响因子:
20.3
通讯作者:
Rodríguez de Córdoba S
中科院分区:
文献类型:
--
作者:
Martín Merinero H;Zhang Y;Arjona E;Del Angel G;Goodfellow R;Gomez-Rubio E;Ji RR;Michelena M;Smith RJH;Rodríguez de Córdoba S
Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathy, and complement dysregulation due to pathogenic variants in factor H (FH) is a recognized cause. The clinical utility of genetic testing in aHUS is limited by the large number of variants reported as “variants of uncertain significance” for the FH gene. Martin Merinero and colleagues functionally characterized 105 FH variants and provide critical data that improve understanding of their clinical significance and should better informclinical practice. Functional characterization of 105 aHUS-associated FH variants reveals limitations of routinely used variant-classification methods. Adapting prediction algorithms to FH domains markedly improves variant classification, and rarity in control databases can be misleading. Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathy that can progress, when untreated, to end-stage renal disease. Most frequently, aHUS is caused by complement dysregulation due to pathogenic variants in genes that encode complement components and regulators. Among these genes, the factor H (FH) gene, CFH, presents with the highest frequency (15% to 20%) of variants and is associated with the poorest prognosis. Correct classification of CFH variants as pathogenic or benign is essential to clinical care but remains challenging owing to the dearth of functional studies. As a result, significant numbers of variants are reported as variants of uncertain significance. To address this knowledge gap, we expressed and functionally characterized 105 aHUS-associated FH variants. All FH variants were categorized as pathogenic or benign and, for each, we fully documented the nature of the pathogenicity. Twenty-six previously characterized FH variants were used as controls to validate and confirm the robustness of the functional assays used. Of the remaining 79 uncharacterized variants, only 29 (36.7%) alter FH expression or function in vitro and, therefore, are proposed to be pathogenic. We show that rarity in control databases is not informative for variant classification, and we identify important limitations in applying prediction algorithms to FH variants. Based on structural and functional data, we suggest ways to circumvent these difficulties and, thereby, improve variant classification. Our work highlights the need for functional assays to interpret FH variants accurately if clinical care of patients with aHUS is to be individualized and optimized.
登录
查看更多内容
DOI:
10.4049/jimmunol.0804031
发表时间:
2009-06-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Ferreira VP;Herbert AP;Cortés C;McKee KA;Blaum BS;Esswein ST;Uhrín D;Barlow PN;Pangburn MK;Kavanagh D
通讯作者:
Kavanagh D
影响因子:
20.3
作者:
Martin Merinero H;Subías M;Pereda A;Gómez-Rubio E;Juana Lopez L;Fernandez C;Goicoechea de Jorge E;Martin-Santamaria S;Cañada FJ;Rodríguez de Córdoba S
通讯作者:
Rodríguez de Córdoba S
影响因子:
13.6
作者:
de Jorge, Elena Goicoechea;Tortajada, Agustin;de Cordoba, Santiago Rodriguez
通讯作者:
de Cordoba, Santiago Rodriguez
影响因子:
3.6
作者:
Montes, Tamara;Goicoechea de Jorge, Elena;Rodriguez de Cordoba, Santiago
通讯作者:
Rodriguez de Cordoba, Santiago
影响因子:
30.8
作者:
Kircher, Martin;Witten, Daniela M.;Jain, Preti;O'Roak, Brian J.;Cooper, Gregory M.;Shendure, Jay
通讯作者:
Shendure, Jay